Delivery Order SPE2DB22D1017-SPE2DB24FG2LL

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,767.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOLU-CORTEF 100 MG ACT-O-VIALS, a pharmaceutical product, with a completion date of June 26, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,790.60, is for the supply of pharmaceutical products and medical supplies to support federal healthcare programs and military treatment facilities. The award has a firm fixed price pricing type and a completion date of October 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order, valued at $5,279.42, is for the supply of pharmaceutical products and medical supplies to support the DLA's medical programs. The award has a firm fixed-price contract type and an ultimate completion date of September 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. government,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical products and medical supplies. The delivery order, valued at $10,077.86, has a firm fixed-price contract type and an ultimate completion date of October 8, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded multiple federal contracts and Indefinite Delivery Contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $17,234.82 firm fixed-price contract is for the supply of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies and equipment. The award does not have a set-aside designation. As a large pharmaceutical distributor, Amerisourcebergen leverages its...
This is a delivery order award to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $27,500.84, is for the supply of pharmaceutical products and medical supplies to support federal healthcare programs and facilities, including military treatment facilities and veterans' hospitals. The contract has a firm-fixed-price pricing type and an ultimate completion date of...
This is a delivery order award to Amerisourcebergen Drug Corp Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award, with a ceiling value of $2,747.84, was made by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products to support military treatment programs and facilities worldwide. The delivery order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $5,030.04 firm-fixed-price delivery order is for the supply of pharmaceutical and medical products, with an ultimate completion date of August 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical products and medical supplies. The award, valued at $21,981.36, has a firm fixed-price contract type and an ultimate completion date of September 3, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as the Department of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract, valued at $44,234.70, is for the supply of various pharmaceutical products and medical supplies to support military treatment facilities and federal healthcare programs. The contract is a firm-fixed-price delivery order with a period of performance through July 2024. Amerisourcebergen has been...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2LL
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 250 mg SOLU-CORTEF Act-O-Vials. The award, valued at $2,372.78, has a firm fixed price and an ultimate completion date of August 5, 2024. Amerisourcebergen, through its corporate office division, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of pharmaceutical and medical products to various government agencies, including the DLA and the Department of Justice Federal Bureau of Investigation. These contracts enable the government to efficiently procure essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This particular award is not designated as a set-aside contract.

Generated 11/1/24, 9:55 AM